3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Dermatologic
1
Conditions
Carcinoma, Basal Cell
2
Sarcoma, Kaposi
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Carcinoma
1
Interventions
Cisplatin
10
Paclitaxel
9
Radiotherapy
5
Fluorouracil
5
Radiotherapy, Intensity-Modulated
4
Docetaxel
4
Carboplatin
4
advexin
2
Therapeutics
2
Surveys and Questionnaires
2
Oxaliplatin
2
Leucovorin
2
Drug Therapy
2
Cetuximab
2
Afatinib
2
penpulimab
1
pembrolizumab
1
olaparib
1
niraparib
1
nimotuzumab
1
nedaplatin
1
durvalumab
1
daromun
1
camrelizumab
1
calcipotriene
1
atezolizumab
1
afamelanotide
1
TP protocol
1
Surgical Procedures, Operative
1
Radiotherapy, Adjuvant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma, Squamous Cell
×
daromun
×
Clear all
NCT05329792
2023-10-06
IntriNSiC
Philogen S.p.A.
Phase 2
Unknown
70 enrolled